AMANTADINE

Search structure
Synonyms:
Status: Approved (1968)
Entry Type: Small molecule
Molecule Category: Parent
ATC: N04BB01
UNII: BF4C9Z1J53

Structure
InChI Key DKNWSYNQZKUICI-UHFFFAOYSA-N
Smile NC12CC3CC(CC(C3)C1)C2
InChI
InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2

Physicochemical Descriptors

Property Name Value
Molecular Formula C10H17N
Molecular Weight 151.25
AlogP 1.91
Hydrogen Bond Acceptor 1.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 0.0
Polar Surface Area 26.02
Molecular species BASE
Aromatic Rings 0.0
Heavy Atoms 11.0

Pharmacology

Primary Target
GluN2C
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Hydrolase
- - - -
Ion channel Ligand-gated ion channel Ionotropic glutamate receptor NMDA receptor
- 92000-358000 - 10000 -
Ion channel Other ion channel Miscellaneous ion channel Type A influenza virus matrix-2 channel family
660-660 4700-199900 2170-210000 - 2-95
Membrane receptor
- - - 20.25 -
Transporter Electrochemical transporter SLC superfamily of solute carriers SLC02 family of hexose and sugar alcohol transporters
- - - - 5.42
Transporter Electrochemical transporter SLC superfamily of solute carriers SLC21/SLCO family of organic anion transporting polypeptides
- - - - 10
Transporter Electrochemical transporter SLC superfamily of solute carriers SLC22 family of organic cation and anion transporters
- 210000-290000 - - -
Transporter Electrochemical transporter SLC superfamily of solute carriers SLC47 family of multidrug and toxin extrusion transporters
- 37800 - - 5
Transporter
- 210000-290000 - - 10

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Brain Injuries 3 D001930 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Psychotic Disorders 3 D011618 ClinicalTrials
Schizophrenia 3 D012559 ClinicalTrials
Multiple Sclerosis 3 D009103 ClinicalTrials
Hepatitis C, Chronic 3 D019698 ClinicalTrials
Stroke 2 D020521 ClinicalTrials
Diabetes Mellitus, Type 2 2 D003924 ClinicalTrials
Infections 2 D007239 ClinicalTrials
Cocaine-Related Disorders 2 D019970 ClinicalTrials
Hepatitis C 2 D006526 ClinicalTrials
Attention Deficit Disorder with Hyperactivity 2 D001289 ClinicalTrials
Pain 2 D010146 ClinicalTrials
Influenza, Human 2 D007251 ClinicalTrials
Cerebral Infarction 2 D002544 ClinicalTrials
Mood Disorders 1 D019964 ClinicalTrials
Mental Disorders 1 D001523 ClinicalTrials

Related Entries

Salt
Salt

Cross References

Resources Reference
CAS NUMBER 768-94-5
ChEBI 2618
ChEMBL CHEMBL660
DrugBank DB00915
DrugCentral 144
EPA CompTox DTXSID8022117
FDA SRS BF4C9Z1J53
Human Metabolome Database HMDB15051
Guide to Pharmacology 4128
KEGG C06818
PharmGKB PA448360
PubChem 2130
SureChEMBL SCHEMBL4098
ZINC ZINC000000968256
CONTENTS